EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of protein-coding genes associated with metastatic prostate cancer

Mina Sattari iD, Hanna Rauhala iD, Leena Latonen, William B Isaacs, Matti Nykter, G Steven Bova, Juha Kesseli, Tapio Visakorpi iD

Endocrine-Related Cancer · 01.07.2025 · 32 (7)

DOI: 10.1530/erc-25-0070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, online erschienen am 17.06.2025. Verfasst von Mina Sattari und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is a significant cause of male mortality worldwide. Since metastases are the underlying cause of lethality, identifying markers for metastatic potential would be highly valuable. To address this issue, we set out to identify protein-coding genes with metastasis-specific expression changes in PCa. We employed a previously reported unique cohort consisting of metastases from castration-resistant prostate cancer (mCRPC) and matching primary tumors. Our comprehensive gene expression analyses identified 85 differentially expressed genes (DEGs) associated specifically with mCRPC, comprising 63 upregulated and 22 downregulated genes. Investigation of the transcription factors (TFs), such as the androgen receptor and its co-regulators FOXA1 and HOXB13, known to be important in prostate tumorigenesis, revealed their involvement in the differential expression of these genes. Furthermore, we identified enriched binding sites for nine TFs, namely EZH2, SUZ12, TLE3, TP63, CBX7, RNF2, SP140, JARID2, and CBX8, in the regulatory regions of the DEGs. Analysis of progression-free survival of prostatectomy-treated men highlighted 16 DEGs with significant prognostic value. Of these, three genes (FRMPD1, TMEM18, and ZNHIT3) were independent prognostic markers of biochemical recurrence. TMEM18 has putative androgen receptor-binding sites in its promoter region, and analysis of LNCaP cells following stimulation with dihydrotestosterone revealed a significant upregulation of TMEM18, confirming the androgen regulation of the gene. Furthermore, we confirmed the prognostic significance of TMEM18 expression at the protein level with immunohistochemistry (IHC) in a primary PCa tumor cohort. In conclusion, we identified 85 mCRPC-associated genes and showed that TMEM18 has prognostic value in early PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantProstatic NeoplasmsMaleHumansNeoplasm MetastasisGene Expression Regulation, NeoplasticHepatocyte Nuclear Factor 3-alphaBiomarkers, TumorPrognosisReceptors, Androgen

Stichwörter der Autor:innen

metastatic prostate cancerprotein-coding gene

Substanzen

Hepatocyte Nuclear Factor 3-alphaBiomarkers, TumorFOXA1 protein, humanReceptors, Androgen

Autor:innen und Institutionen

ORCID-Profile: Mina Sattari, Hanna Rauhala, Tapio Visakorpi

Zitieren

APA

Sattari, M., Rauhala, H., Latonen, L., Isaacs, W. B., Nykter, M., Bova, G. S., Kesseli, J., & Visakorpi, T. (2025). Identification of protein-coding genes associated with metastatic prostate cancer. Endocrine-Related Cancer, 32(7). https://doi.org/10.1530/erc-25-0070

Vancouver

Sattari M, Rauhala H, Latonen L, Isaacs WB, Nykter M, Bova GS, et al. Identification of protein-coding genes associated with metastatic prostate cancer. Endocrine-Related Cancer. 2025;32(7). doi:10.1530/erc-25-0070

BibTeX
@article{Sattari2025,
  author = {Sattari, Mina and Rauhala, Hanna and Latonen, Leena and Isaacs, William B and Nykter, Matti and Bova, G Steven and Kesseli, Juha and Visakorpi, Tapio},
  title = {Identification of protein-coding genes associated with metastatic prostate cancer},
  journal = {Endocrine-Related Cancer},
  year = {2025},
  volume = {32},
  number = {7},
  doi = {10.1530/erc-25-0070}
}
Kostenlos starten →